海关总署:对检出新冠病毒的进口冷链食品境外生产商实施紧急预防性措施

2020-09-11 海关总署官网 海关总署官网

9月11日下午,海关总署发布《对检出新冠病毒核酸阳性的进口冷链食品境外生产企业实施紧急预防性措施的公告》:

9月11日下午,海关总署发布《对检出新冠病毒核酸阳性的进口冷链食品境外生产企业实施紧急预防性措施的公告》:

为防范新冠肺炎疫情通过进口冷链食品输入风险,保护消费者身体健康安全,海关对检出新冠病毒核酸阳性的进口冷链食品境外生产企业实施紧急预防性措施,具体如下:

同一境外生产企业输华冷链食品或其包装第1次和第2次被检出新冠病毒核酸阳性的,海关分别暂停接受该企业产品进口申报1周,期满后自动恢复;同一境外生产企业先后被检出新冠病毒核酸阳性3次及以上的,海关暂停接受该企业产品进口申报4周,期满后自动恢复。

本公告自发布之日起生效。

特此公告。

海关总署

2020年9月11日

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2034837, encodeId=ddd1203483e68, content=<a href='/topic/show?id=69c910030635' target=_blank style='color:#2F92EE;'>#预防性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100306, encryptionId=69c910030635, topicName=预防性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45b2276, createdName=839640778, createdTime=Wed May 19 01:49:25 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1517833, encodeId=7d86151e833a6, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68866, encryptionId=44156886664, topicName=生产)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37a111112788, createdName=ms1343860338762272, createdTime=Sun Sep 13 13:49:25 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523309, encodeId=42d01523309b4, content=<a href='/topic/show?id=1a1de7006b0' target=_blank style='color:#2F92EE;'>#紧急#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77006, encryptionId=1a1de7006b0, topicName=紧急)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88211514540, createdName=guguangxiang, createdTime=Sun Sep 13 13:49:25 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028542, encodeId=68c8102854260, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Sep 12 01:49:25 CST 2020, time=2020-09-12, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2034837, encodeId=ddd1203483e68, content=<a href='/topic/show?id=69c910030635' target=_blank style='color:#2F92EE;'>#预防性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100306, encryptionId=69c910030635, topicName=预防性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45b2276, createdName=839640778, createdTime=Wed May 19 01:49:25 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1517833, encodeId=7d86151e833a6, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68866, encryptionId=44156886664, topicName=生产)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37a111112788, createdName=ms1343860338762272, createdTime=Sun Sep 13 13:49:25 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523309, encodeId=42d01523309b4, content=<a href='/topic/show?id=1a1de7006b0' target=_blank style='color:#2F92EE;'>#紧急#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77006, encryptionId=1a1de7006b0, topicName=紧急)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88211514540, createdName=guguangxiang, createdTime=Sun Sep 13 13:49:25 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028542, encodeId=68c8102854260, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Sep 12 01:49:25 CST 2020, time=2020-09-12, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2034837, encodeId=ddd1203483e68, content=<a href='/topic/show?id=69c910030635' target=_blank style='color:#2F92EE;'>#预防性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100306, encryptionId=69c910030635, topicName=预防性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45b2276, createdName=839640778, createdTime=Wed May 19 01:49:25 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1517833, encodeId=7d86151e833a6, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68866, encryptionId=44156886664, topicName=生产)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37a111112788, createdName=ms1343860338762272, createdTime=Sun Sep 13 13:49:25 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523309, encodeId=42d01523309b4, content=<a href='/topic/show?id=1a1de7006b0' target=_blank style='color:#2F92EE;'>#紧急#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77006, encryptionId=1a1de7006b0, topicName=紧急)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88211514540, createdName=guguangxiang, createdTime=Sun Sep 13 13:49:25 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028542, encodeId=68c8102854260, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Sep 12 01:49:25 CST 2020, time=2020-09-12, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2034837, encodeId=ddd1203483e68, content=<a href='/topic/show?id=69c910030635' target=_blank style='color:#2F92EE;'>#预防性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100306, encryptionId=69c910030635, topicName=预防性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45b2276, createdName=839640778, createdTime=Wed May 19 01:49:25 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1517833, encodeId=7d86151e833a6, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68866, encryptionId=44156886664, topicName=生产)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37a111112788, createdName=ms1343860338762272, createdTime=Sun Sep 13 13:49:25 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523309, encodeId=42d01523309b4, content=<a href='/topic/show?id=1a1de7006b0' target=_blank style='color:#2F92EE;'>#紧急#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77006, encryptionId=1a1de7006b0, topicName=紧急)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88211514540, createdName=guguangxiang, createdTime=Sun Sep 13 13:49:25 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028542, encodeId=68c8102854260, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Sep 12 01:49:25 CST 2020, time=2020-09-12, status=1, ipAttribution=)]
    2020-09-12 公卫新人

    新冠肺炎,疫情何时才能消失

    0

相关资讯

Nat Neurosci:对小鼠,非人类灵长类动物和人类中功能不同的中间神经元进行病毒操作

大规模的转录组研究正在迅速揭示在特定细胞类型中何时何地表达与神经精神疾病相关的基因。理解和治疗这些疾病的方法将需要靶向和操纵特定神经元亚型的方法。因此,在非人类灵长类动物和人类中接触这些人群已变得至关

Cell Rep:国内学者在发热伴血小板减少综合征病毒诱发炎症反应研究方面取得新进展

研究团队通过运用临床病人样本转录组和定量蛋白质组的多维组学研究方法来揭示SFTSV感染的潜在致病机制。

Nat BME :集成方法可加快发现抗病毒抗体疗法的速度

近年来,人类B细胞的分离和抗体可变基因测序技术的进步已导致鉴定出针对许多威胁生命的病毒病原体的大量治疗性单克隆抗体候选物。这些目标包括抗原可变病毒,例如HIV1和流感病毒,具有高流行潜力的新兴病原体,

单日新增1565病例创新高!新冠病毒变异了?

日增1565例创新高!大规模感染因为病毒变异?

Oncogene:肾移植患者BK多瘤病毒相关尿道肿瘤的病毒整合情况研究

移植后与BK多瘤病毒(BKPyV)相关的癌症已经引起了越来越多的注意。然而,BKPyV与致瘤过程的整合作用仍旧不清楚。

警惕!研究称部分新冠患者康复后粪便内病毒仍具传染性

香港中文大学(中大)医学院7日在记者会上宣布,首次证实新冠肺炎患者即使无肠胃不适症状,肠道及粪便内都会发现活跃新冠病毒;部分患者康复后,粪便内病毒仍具传染性及可复制性。同日,中大新冠病毒检测中心成立,